460 related articles for article (PubMed ID: 10720442)
1. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels.
Kunjara S; Greenbaum AL; Wang DY; Caro HN; McLean P; Redman CW; Rademacher TW
Mol Genet Metab; 2000 Feb; 69(2):144-58. PubMed ID: 10720442
[TBL] [Abstract][Full Text] [Related]
2. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies.
Scioscia M; Gumaa K; Whitten M; Selvaggi LE; Rodeck CH; Rademacher TW
J Reprod Immunol; 2007 Dec; 76(1-2):85-90. PubMed ID: 17493685
[TBL] [Abstract][Full Text] [Related]
3. Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?
Rademacher TW; Gumaa K; Scioscia M
J Reprod Immunol; 2007 Dec; 76(1-2):78-84. PubMed ID: 17537518
[TBL] [Abstract][Full Text] [Related]
4. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia.
Paine MA; Scioscia M; Gumaa KA; Rodeck CH; Rademacher TW
J Reprod Immunol; 2006 Apr; 69(2):165-79. PubMed ID: 16384607
[TBL] [Abstract][Full Text] [Related]
5. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension.
Scioscia M; Paine MA; Gumaa K; Rodeck CH; Rademacher TW
J Matern Fetal Neonatal Med; 2008 Aug; 21(8):581-5. PubMed ID: 18609357
[TBL] [Abstract][Full Text] [Related]
6. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus.
Scioscia M; Gumaa K; Selvaggi LE; Rodeck CH; Rademacher TW
J Perinat Med; 2009; 37(5):469-71. PubMed ID: 19492925
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus.
Scioscia M; Kunjara S; Gumaa K; McLean P; Rodeck CH; Rademacher TW
Diabet Med; 2007 Nov; 24(11):1300-4. PubMed ID: 17956457
[TBL] [Abstract][Full Text] [Related]
8. Inositol phosphoglycans and preeclampsia: from bench to bedside.
Scioscia M; Williams PJ; Gumaa K; Fratelli N; Zorzi C; Rademacher TW
J Reprod Immunol; 2011 May; 89(2):173-7. PubMed ID: 21549431
[TBL] [Abstract][Full Text] [Related]
9. Endometrial secretions: creating a stimulatory microenvironment within the human early placenta and implications for the aetiopathogenesis of preeclampsia.
Burton GJ; Scioscia M; Rademacher TW
J Reprod Immunol; 2011 May; 89(2):118-25. PubMed ID: 21531028
[TBL] [Abstract][Full Text] [Related]
10. Placental glycogen metabolism in diabetic pregnancy.
Shafrir E; Barash V
Isr J Med Sci; 1991; 27(8-9):449-61. PubMed ID: 1835720
[TBL] [Abstract][Full Text] [Related]
11. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs).
Elased KM; Gumaa KA; de Souza JB; Rahmoune H; Playfair JH; Rademacher TW
Mol Genet Metab; 2001 Jul; 73(3):248-58. PubMed ID: 11461192
[TBL] [Abstract][Full Text] [Related]
12. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus.
Scioscia M; Kunjara S; Gumaa K; Gomez Galan AM; McLean P; Rodeck CH; Rademacher TW
Gynecol Obstet Invest; 2007; 64(4):217-23. PubMed ID: 17664885
[TBL] [Abstract][Full Text] [Related]
13. Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder.
Paine MA; Scioscia M; Williams PJ; Gumaa K; Rodeck CH; Rademacher TW
Hypertens Pregnancy; 2010; 29(4):375-84. PubMed ID: 20701477
[TBL] [Abstract][Full Text] [Related]
14. Inositol phosphoglycan P-type in infants of preeclamptic mothers.
Scioscia M; Robillard PY; Hall DR; Rademacher LH; Williams PJ; Rademacher TW
J Matern Fetal Neonatal Med; 2012 Feb; 25(2):193-5. PubMed ID: 21401313
[TBL] [Abstract][Full Text] [Related]
15. The link between insulin resistance and preeclampsia: new perspectives.
Scioscia M; Gumaa K; Rademacher TW
J Reprod Immunol; 2009 Nov; 82(2):100-5. PubMed ID: 19628283
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2.
Scioscia M; Gumaa K; Kunjara S; Paine MA; Selvaggi LE; Rodeck CH; Rademacher TW
J Clin Endocrinol Metab; 2006 Feb; 91(2):709-17. PubMed ID: 16332940
[TBL] [Abstract][Full Text] [Related]
17. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
18. Placental expression of D-chiro-inositol phosphoglycans in preeclampsia.
Scioscia M; Siwetz M; Fascilla F; Huppertz B
Placenta; 2012 Oct; 33(10):882-4. PubMed ID: 22835680
[TBL] [Abstract][Full Text] [Related]
19. Inositol phosphoglycan P-type in preeclampsia: a novel marker?
Williams PJ; Gumaa K; Scioscia M; Redman CW; Rademacher TW
Hypertension; 2007 Jan; 49(1):84-9. PubMed ID: 17116762
[TBL] [Abstract][Full Text] [Related]
20. Placental imbalance of Th1- and Th2-type cytokines in preeclampsia.
Dong M; He J; Wang Z; Xie X; Wang H
Acta Obstet Gynecol Scand; 2005 Aug; 84(8):788-93. PubMed ID: 16026406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
